Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

15 Sep 2020 13:00

RNS Number : 0655Z
Computacenter PLC
15 September 2020
 

 

 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

Computacenter plc

(the 'Company')

 

The following notifications are made under article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Directors of the Company, Persons Discharging Managerial Responsibilities ('PDMR') of the Company and/or Persons Closely Associated ('PCA') with the Directors and PDMRs.

 

PDMR/PCA FCA Transaction Notification

 

 

1.

 

 

Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Kevin James

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Group Chief Commercial Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired following exercise of a conditional award in accordance with the rules of the Computacenter Performance Share Plan 2005. There was no price payable on the grant or exercise of the award. Vesting was subject to the achievement of performance conditions over a three year period.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

nil

 

12,836

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

nil

 

 

 

12,836

 

4(e)

 

 

Date of the transaction

 

 

11-09-2020

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue. The Ordinary Shares for the above-mentioned exercise were satisfied out of those held by the 2011 Computacenter Employee Benefit Trust.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Sale of Ordinary Shares. Ordinary Shares sold sufficient only to fund the tax and national insurance liabilities and administrative fees arising from the exercise of the option acquired from the conditional award vested under the rules of the Computacenter Performance Share Plan 2005.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

23.04

 

6,050

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

23.04

 

 

 

6,050

 

4(e)

 

 

Date of the transaction

 

 

11-09-2020

 

 

4(f)

 

 

Place of the transaction

 

 

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAFNSFLSEEFA
Date   Source Headline
28th May 20267:00 amRNSAcquisition of Government Acquisitions Inc
19th May 20262:00 pmRNSResult of AGM
8th May 20262:00 pmRNSDirector/PDMR Shareholding
28th Apr 20261:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSQ1 Trading Update – 24 April 2026
8th Apr 202610:00 amRNS2025 Annual Financial Report & Notice of 2026 AGM
27th Mar 202610:00 amRNSDirector/PDMR Shareholding
25th Mar 20263:00 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSFinal Results 2025
5th Feb 20261:00 pmRNSBlock Listing Interim Review
22nd Jan 20267:00 amRNSPre-Close Trading Update – 22 January 2026
8th Jan 20267:00 amRNSAcquisition of AgreeYa Solutions Inc
6th Nov 20251:00 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSDirectorate Change
5th Aug 20251:00 pmRNSBlock listing Interim Review
31st Jul 20255:00 pmRNSHolding(s) in Company
31st Jul 20254:30 pmRNSDirector/PDMR Shareholding
28th Jul 20257:00 amRNSTrading Update – 28 July 2025
26th Jun 20253:00 pmRNSDirector/PDMR Shareholding
15th May 20255:00 pmRNSResult of AGM
13th May 20255:45 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
6th May 20253:00 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSQ1 Trading Update
9th Apr 20252:30 pmRNS2024 Annual Financial Report & Notice of 2025 AGM
2nd Apr 20252:30 pmRNSDirector/PDMR Shareholding
28th Mar 202510:00 amRNSDirector/PDMR Shareholding
26th Mar 20252:00 pmRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results 2024
6th Feb 202510:00 amRNSBlock listing Interim Review
28th Jan 20257:00 amRNSPre-Close Trading Update
9th Jan 20257:00 amRNSDirectorate Change
16th Dec 20247:00 amRNSDirectorate Change
7th Nov 20245:00 pmRNSDirector/PDMR Shareholding
1st Nov 202412:00 pmRNSTotal Voting Rights
30th Oct 20246:14 pmRNSTransaction in Own Shares
30th Oct 20242:00 pmRNSDirector/PDMR Shareholding
29th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20246:05 pmRNSTransaction in Own Shares
28th Oct 20247:00 amRNSQ3 Trading Update – 28 October 2024
25th Oct 20245:33 pmRNSTransaction in Own Shares
24th Oct 202412:00 pmRNSCancellation of Shares held in Treasury
24th Oct 20249:30 amRNSQ3 Trading Update - Release Date
23rd Oct 20245:49 pmRNSTransaction in Own Shares
22nd Oct 20246:18 pmRNSTransaction in Own Shares
18th Oct 20245:49 pmRNSTransaction in Own Shares
17th Oct 20245:48 pmRNSTransaction in Own Shares
16th Oct 20246:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.